pubrio
Callio Therapeutics

Callio Therapeutics

United States · Research

Research

We’re advancing next-gen multi-payload ADCs with unique payload and linker tech to deliver dual agents to tumor cells, maximizing benefits for cancer patients.

Company Insights
Company Overview

2024

Founded

Research

Industry

United States

Location

21,839,343

Ranking

9 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Callio Therapeutics

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​